Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
08/2000
08/23/2000EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
08/23/2000EP0711289B1 Piperazine compounds used in therapy
08/23/2000CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia
08/23/2000CN1055687C Novel piperazine carboxamides
08/23/2000CN1055682C Process for preparing mesylamido-phenethylamine derivative
08/23/2000CA2299119A1 A method of stabilizing and/or isolating nucleic acids
08/22/2000US6107519 Amido-substituted secondary alcohol intermediates and preparation thereof
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107329 Hypotensive agents; cardiovascular disorders
08/22/2000CA2165992C Disulphides
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047547A2 Cycloalkyl amine compounds and uses thereof
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2361428A1 Inhibitors of factor xa
08/16/2000EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
08/16/2000EP1027328A1 Substituted anilides
08/16/2000EP1026950A1 Treatment of schizophrenia with ampakines and neuroleptics
08/16/2000EP0877612B1 Use of piperazine derivatives for the treatment of cognitive disorders
08/16/2000EP0755374B1 Process for peptide segment condensation
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103776 Phenolic amides and their use as stabilizers
08/15/2000US6103720 Ketobenzamides as calpain inhibitors
08/15/2000US6103719 Neurokinin-a- or neurokinin-b tachnkinin antagonistic properties; substance p antagonism; respiratory, gastrointestinal, nervous system, skin disorders;
08/15/2000US6103700 Fluoro labelled anthracyclinone and anthracycline derivatives
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046191A1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
08/10/2000WO2000046187A2 Antizyme modulators and their use
08/10/2000WO2000046184A1 N2-phenylamidine derivatives
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000CA2362259A1 Antizyme modulators and their use
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/09/2000EP1026150A1 (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same
08/09/2000EP1026149A1 Amidocarboxylic acid derivatives
08/09/2000EP1025107A1 Photochromic compounds
08/09/2000EP1025097A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP0823068B1 Color-providing compounds
08/09/2000CN1262667A Reduction of carbonyl compounds by silane in presence of zinc catalyst
08/09/2000CN1262618A NF-KB inhibitors containing as active ingredient phenylmethyl benzoquinone
08/09/2000CN1262600A Compositions and method for reducing respiratory depression and attendant side effects of mu opioid compounds
08/09/2000CN1262272A HIV proteinase inhibitor
08/08/2000US6100428 Reacting optionally protected thioureas and isothioureas with amines in the presence of a nickel catalyst to form a compound comprising a guanidine; high yields, mild reaction conditions
08/08/2000US6100400 Process for the preparation of esters of [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid
08/08/2000US6100280 Administering a 1-(bis(fluorophenyl)alkyl)-4-(2-oxy-3-(aryl substituted amino)propyl)piperazine derivative to treat narcotic drug dependency with reduced side effects
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/03/2000WO2000044770A1 Substituted phenethylamine derivatives
08/03/2000WO2000044734A1 Compounds comprising acrylate and cyclic sec.-amine functionalities
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044379A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000018750A3 Chelates comprising chinoid groups as photoinitiators
08/03/2000WO2000008006A3 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO2000003975A3 Aryl vinyl ether derivatives and their use as herbicides
08/03/2000DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis
08/03/2000CA2359030A1 Substituted phenethylamine derivatives
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023356A1 Specific fluorinated ethers as reaction medium
08/02/2000EP1023278A1 Process for preparing substituted pyrazine compounds
08/02/2000CN1261892A Diphosphonic acid salts for treatment of osteoporsis
08/02/2000CN1261883A Novel compounds
08/02/2000CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
08/02/2000CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
08/02/2000CN1261795A Compounds and methods
08/02/2000CN1261534A Medicinal composition containing naphthyl compound
08/01/2000US6096917 Carboxy-substituted octahydrophenanthrene-oximes and hydrazones
08/01/2000US6096888 Anthracyclinone derivatives and their use in amyloidosis
08/01/2000US6096779 Amorphous piretanide, piretanide polymorphs, process for their preparation and their use
08/01/2000US6096760 Solid α-phenyl-2-piperidine acetate free base, its preparation and use in medicine
08/01/2000US6096741 Oxime derivatives, hydrazone derivatives and use thereof
08/01/2000US6096098 Asymmetrical bleach activators and compositions employing the same
08/01/2000CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists
08/01/2000CA2019335C Phenylalkan (en)oic acids
08/01/2000CA2015034C Piperazine derivatives
07/2000
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043368A1 Novel cationic 2-acylaminophenols, their use as coupler for oxidation dyeing, compositions containing them, and dyeing methods
07/27/2000WO2000043356A1 Novel cationic couplers and their use for oxidation dyeing
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000042980A1 Naphthalene cationic coupler for oxidation dyeing of keratin fiber
07/27/2000WO2000042979A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
07/27/2000WO2000042971A2 Novel cationic 2-sulphonylaminophenols, their use as couplers for oxidation dyeing, compositions containing them and dyeing methods
07/27/2000WO2000042852A1 Compounds and methods
07/27/2000WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors
07/27/2000WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359105A1 New morpholinobenzamide salts
07/27/2000CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4